SBRA Relative Valuation
SBRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SBRA is overvalued; if below, it's undervalued.
Historical Valuation
Sabra Health Care REIT Inc (SBRA) is now in the Fair zone, suggesting that its current forward PS ratio of 5.83 is considered Fairly compared with the five-year average of 27.11. The fair price of Sabra Health Care REIT Inc (SBRA) is between 15.05 to 18.53 according to relative valuation methord.
Relative Value
Fair Zone
15.05-18.53
Current Price：18.12
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.61
P/B
Median3y
1.19
Median5y
1.11
7.72
FCF Yield
Median3y
9.39
Median5y
9.84
Competitors Valuation Multiple
The average P/S ratio for SBRA's competitors is 5.37, providing a benchmark for relative valuation. Sabra Health Care REIT Inc Corp (SBRA) exhibits a P/S ratio of 5.83, which is 8.48% above the industry average. Given its robust revenue growth of 10.07%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Sabra Health Care REIT Inc (SBRA) currently overvalued or undervalued?
What is Sabra Health Care REIT Inc (SBRA) fair value?
How does SBRA's valuation metrics compare to the industry average?
What is the current P/B ratio for Sabra Health Care REIT Inc (SBRA) as of Jul 18 2025?
What is the current FCF Yield for Sabra Health Care REIT Inc (SBRA) as of Jul 18 2025?
What is the current Forward P/E ratio for Sabra Health Care REIT Inc (SBRA) as of Jul 18 2025?